Schools across the country are offering courses and retreats for people 50+ who want to reinvent themselves and embrace lifelong learning and discovery.
The 2026 NFL divisional round schedule features two games on Sunday with Texans vs. Patriots (-3.5, 40.5) and Rams (-4.5, 48.5) vs. Bears. These are moderate NFL spreads and fall in between what the ...
Recent Exact Sciences Corporation financials show accelerating revenue growth and stable margins, despite ongoing investments in screening and MRD. While EXAS maintains leadership in stool-based CRC ...
Forbes contributors publish independent expert analyses and insights. I write about relationships, personality, and everyday psychology. You might see your career as separate from your internal world.
WASHINGTON – The U.S. Army has established a new career pathway for officers to specialize in artificial intelligence and machine learning (AI/ML), formally designating the 49B AI/ML Officer as an ...
The NFL Week 17 schedule rolls on with 10 games on Sunday and then the standard 'Monday Night Football' slot. Several of the remaining games have a direct bearing on the NFL playoffs and seeding. In ...
The PATH transit system rolled out its new, reloadable TAPP (Total Access PATH Payment) fare card on Thursday as Port Authority moves toward phasing out its antiquated MetroCard and SmartLink systems ...
Pour one out for the ancient MetroCard and its equally old cousin, the PATH SmartLink card. The beginning of the end for these longtime ways to pay fares on the bi-state PATH system came Thursday when ...
Abbott is getting into cancer testing with its $21 billion acquisition Exact Sciences, the maker of the game-changing colorectal cancer test Cologuard. Abbott markets well-known diagnostics for ...
Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...
Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results